>Brookings Oregon News, Sports, & Weather | The Curry Coastal Pilot

News Classifieds Web
web powered by Web Search Powered by Google

News arrow News arrow Business arrow Former Brookings woman creates health supplement

Former Brookings woman creates health supplement Print E-mail
Written by Marge Woodfin, Pilot staff writer   
August 12, 2009 08:58 am

Lisa Lent
Lisa Lent
The story might be called “Hometown Girl Makes Good.” 

Lisa Lent, a former Brookings-Harbor High School student, is currently the founder and chief executive of Vitalah, LLC. Her company produces Oxylent, an award-winning diet supplement that users are quoted as saying helps to keep them healthy and active.

Lisa, who moved to Brookings with her parents, Sheldon and Gro Lent, in 1982 as an 11-year-old fourth grader, has traveled far and literally flown high since her school days in Brookings.

Her early career as a flight attendant led her to the discovery of Oxylent, after being diagnosed at age 29 with pulmonary embolus, multiple clots in her lungs.

Lisa is not a quitter and that diagnosis only made her determined to find a solution to her health problem. She discovered evidence that convinced her that her many hours as a flight attendant, experiencing low oxygen, cabin pressure, dehydration, and radiation could be contributing factors.

As a young girl growing up in Brookings, Lisa exhibited determination to follow her dreams.

Her passion for horseback riding kept her in the saddle even after her beloved horse was hit by a vehicle and had to be put down.

In high school she performed with the Bear Delights when they won first place at state level. Her mother said recently, “She loved being part of a team.”.

Her mother also remembered that Lisa always wanted to help people and loved to travel, no doubt influencing her choice of flight attendant for a career.

Determination to find help for health problems kept Lisa on track, and in 2008, with help from a team of health industry leaders, she created Oxylent. Originally created with the idea of helping airline employees and constant air travelers, Oxylent has also proven to be popular with those in any career looking for better health.

Lisa is looking forward to greeting old friends and meeting new while in Brookings. She has scheduled a demonstration of Oxylent at the Brookings Natural Foods Store, 630 Chetco Ave., from noon to 3 p.m. Saturday, Aug. 15.

Joyce Tromblee, owner of the food store and strong proponent of healthy living, said about Lisa’s product, “I think it’s great stuff. It has all the things in it that other products don’t have. It covers the whole spectrum.”

Lisa’s message to all is, “Follow your heart and your passion and never give up on your dreams.”

 

Business News by Yahoo Finance

  • Pipeline delay gives boost to Obama's political base
    The latest delay to a final decision on the Keystone XL oil pipeline will reinforce a White House strategy to energize President Barack Obama's liberal-leaning base before fall elections in which Democrats risk losing control of the U.S. Senate. Environmentalists, worried about the project's effect on climate change, have put enormous pressure on the president to reject the pipeline from Canada's oil sands, staging demonstrations outside the White House and protests in states where he travels. A decision to approve it now could have prompted that vocal group, which was instrumental in electing Obama in 2008 and 2012, to sit out the November 4 congressional elections. The State Department's announcement on Friday that it would give government agencies more time to study the project was seen by strategists from both parties as a move to prevent that and boost Obama in the eyes of his supporters.
  • Pfizer considers $100 billion bid for AstraZeneca: report
    U.S. pharmaceutical giant Pfizer (PFE) has approached British rival AstraZeneca (AZN.L) to propose a 60 billion pound ($101 billion) takeover, Britain's Sunday Times reported. The paper cited senior investment bankers and industry sources saying that informal conversations about a deal had taken place between the two but that no talks were currently under way after AstraZeneca resisted the approach. Pfizer and AstraZeneca both declined to comment on the report to Reuters. AstraZeneca, Britain's second-biggest pharmaceuticals group, has been frequently touted as a potential takeover target as it wrestles with patents expiring on a number of best-selling drugs, leaving future growth uncertain.
  • Wall Street Week Ahead: Spring fever brings hope for U.S. earnings
    Several behemoths, including Apple, the largest U.S. company by market value, as well as Microsoft, McDonald's (MCD.N) and AT&T (NYS:T), are due to report earnings. They'll be accompanied by highfliers like Netflix and Facebook, giving the first real cross-section of the state of corporate America as temperatures rise across the country and investors hope to put the cold weather behind them. Strategists will also be looking for clues on how badly China's slowdown hits U.S. corporate results. The first batch of earnings came out as equities were working their way through a selloff led by trading-crowd favorites like Netflix and the biotech stocks.

Follow Curry Coastal Pilot headlines on Follow Curry Coastal Pilot headlines on Twitter

© Copyright 2001 - 2014 Western Communications, Inc. All rights reserved. By Using this site you agree to our Terms of Use